Stay updated on EMPIRE CF: CTX-4430 Clinical Trial

Sign up to get notified when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EMPIRE CF: CTX-4430 Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier was updated from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T02:20:30.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A sitewide NIH notice appears above the ClinicalTrials.gov study-record error page, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T02:27:55.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T02:05:53.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site’s footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T03:16:05.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study record content. This blocks access to the study details and navigation on that page.
    Difference
    18%
    Check dated 2026-09-20T01:30:05.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, reflecting a small behind-the-scenes update to the page's revision tracking.
    Difference
    0.0%
    Check dated 2026-08-29T22:07:22.000Z thumbnail image

Stay in the know with updates to EMPIRE CF: CTX-4430 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EMPIRE CF: CTX-4430 Clinical Trial page.